Sector Gamma AS Buys 37,390 Shares of GE HealthCare Technologies Inc. $GEHC

Sector Gamma AS boosted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 50.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 111,390 shares of the company’s stock after acquiring an additional 37,390 shares during the quarter. GE HealthCare Technologies accounts for approximately 2.1% of Sector Gamma AS’s portfolio, making the stock its 17th largest holding. Sector Gamma AS’s holdings in GE HealthCare Technologies were worth $8,365,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in GEHC. Empowered Funds LLC raised its holdings in shares of GE HealthCare Technologies by 6.1% during the 1st quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock valued at $2,328,000 after buying an additional 1,665 shares in the last quarter. Acadian Asset Management LLC bought a new position in GE HealthCare Technologies during the first quarter valued at approximately $259,000. Farther Finance Advisors LLC grew its position in GE HealthCare Technologies by 16.4% during the second quarter. Farther Finance Advisors LLC now owns 5,228 shares of the company’s stock valued at $387,000 after acquiring an additional 735 shares during the last quarter. American National Bank & Trust raised its stake in shares of GE HealthCare Technologies by 29.5% during the second quarter. American National Bank & Trust now owns 1,717 shares of the company’s stock worth $127,000 after acquiring an additional 391 shares in the last quarter. Finally, CX Institutional lifted its holdings in shares of GE HealthCare Technologies by 24.8% in the 2nd quarter. CX Institutional now owns 4,858 shares of the company’s stock worth $360,000 after acquiring an additional 965 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the stock. Jefferies Financial Group upped their price target on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a research report on Thursday, December 11th. The Goldman Sachs Group reiterated a “buy” rating and issued a $98.00 price objective on shares of GE HealthCare Technologies in a research report on Friday, January 9th. Citigroup upped their price target on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the company a “neutral” rating in a report on Thursday, December 11th. Evercore ISI reaffirmed an “outperform” rating and set a $95.00 price objective on shares of GE HealthCare Technologies in a research note on Monday, January 5th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Monday, December 29th. Seven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $89.83.

GE HealthCare Technologies Trading Down 2.6%

NASDAQ:GEHC opened at $79.77 on Friday. The company has a 50-day moving average price of $81.98 and a 200-day moving average price of $77.22. The stock has a market cap of $36.34 billion, a price-to-earnings ratio of 16.48, a P/E/G ratio of 2.41 and a beta of 1.08. The company has a current ratio of 1.18, a quick ratio of 0.95 and a debt-to-equity ratio of 0.83. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.05 by $0.02. The company had revenue of $5.14 billion during the quarter, compared to the consensus estimate of $5.07 billion. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. GE HealthCare Technologies’s revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the firm earned $1.14 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Equities analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be given a dividend of $0.035 per share. The ex-dividend date is Friday, January 9th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 2.89%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.